The ongoing pandemic has brought forward the realization that viruses and bacteria can live both in the air and on surfaces and thus spread and have a major impact on our health. Making sure our indoor environments are safe has never been more important. That is why BrainLit has developed a solution to eliminate viruses and other pathogens, including SARS-CoV-2, the virus causing Covid-19, in an entirely automatic, safe and efficient way using light.
At BrainLit, we want to spread the knowledge about light further. By subscribing to our list, you will be among the first to learn about future light technologies. You will also receive the BrainLit UVen product brochure. Register your interest by filling out the form.
BrainLit UVen has gone through tests by the Swedish Defence Research Agency (FOI), which verifies the disinfection efficacy with quick deactivation of SARS-CoV-2, i.e. the virus that causes Covid 19.
BrainLit is a health technology company that focuses on delivering light that improves health and well-being with measurable results. The technology was developed by a research team in Lund and the first patent was submitted as early as 2012. The patent portfolio has since grown and the company sells a number of different lighting systems that are adapted to the needs of people and organizations.
BrainLit is best known for BioCentric Lighting ™, a patented technology that delivers imitated daylight indoors to help you maintain your natural circadian rhythm. There is good documentation that proves the good impact of light on the health, well-being and productivity of those who work, study or stay in premises with BioCentric Lighting ™.
In the Nordic region, Swedbank, Castellum, EY and Sony, among others, have chosen BrainLit’s lighting environments, and together with partner Arjo, specially adapted solutions in healthcare and healthcare are also delivered. The BrainLit UVen is available for order in CE-certified markets and is already installed among customers.